EOS showcases copper-infused surface solution that actively reduces bacteria 24/7


EOS Surfaces, LLC, a leading surfaces technology developer and manufacturer dedicated to innovation that increases patient safety and reduces costs of care, will showcase its EOScu Preventive|Biocidal Surfaces™ (Cupron Enhanced EOS) at IDWeek 2015. EOScu is the only synthetic copper-infused hard surface EPA-registered to make public health claims for its ability to actively and continuously kill 99.9% of gram negative and gram positive bacteria* within two hours of exposure, even after recontamination. EOScu is used in healthcare facilities on known high-touch, highly contaminated areas, such as hospital bed rails, overbed tables, and sink bowls, as well as in high- traffic areas like nurses’ stations in an effort to help reduce the spread of bacteria from surfaces to patients. As a result, the Preventive|Biocidal Surfaces serve as an integral part of infection control protocols aimed at decreasing the incidence of hospital acquired infections (HAIs).

As the only hard, synthetic surface registered for public health claims by the EPA, EOScu is proven to reduce the bioburden of the patient environment by 99.9% within two hours of exposure – self-sanitizing at least 12 times per day. EPA registration is only given to products that meet the highest standards of efficacy, requiring rigorous testing of claims that are done in environments significantly more contaminated than what is typically found in healthcare facilities. The EPA grants registration only to those products that can meet the highest possible standards.

“We designed EOScu to help infection control professionals and healthcare facilities protect patients and reduce costs associated with readmissions. The testing we have done on EOScu and the standards we have met give hospital purchasers and consumers peace of mind that the surface itself is working with existing protocols to ensure a cleaner, safer environment for patients, staff and the community,” said Ken Trinder, CEO of EOS Surfaces, the manufacturer of EOScu.

EOS continues to test the surface’s efficacy in real world environments, including being part of the world’s largest known clinical trial testing the efficacy of copper in a healthcare setting at Sentara Leigh Hospital in Norfolk, Virginia. All 250 patient rooms and accompanying work areas are outfitted with EOScu Preventive|Biocidal Surfaces™, including countertops, over-the-bed tables and bed rails. 

Continuous bacteria reduction between routine cleanings

According to the Centers for Disease Control and Prevention (CDC), HAIs cause 75,000 deaths per year in U.S. hospitals and add up to $45 billion per year to healthcare costs[1], creating an urgent need for facilities to find innovative and effective ways to reduce the spread of bacteria and the incidence of HAIs. Even with rigorous sanitation protocols, bacteria can repopulate on a surface and spread quickly through human-to-human or human-to-surface contact. By constantly killing bacteria, EOScu helps fill the gaps between punctate cleaning shifts. The surface works without the need for any extra human processes after installation.

ROI in as little as one year

HAIs bring financial implications beyond a patient’s cost of care as high HAI rates directly impact a healthcare facility’s bottom line. Under the ACA, high readmission and HAI rates impact reimbursement, lost revenue and patient satisfaction. EOScu is a one-time investment that offers a return on investment (ROI) in as little as one year, based on the potential savings derived by the reduction of HAIs.

The IDWeek conference, which takes place October 7 to 11 at the San Diego Convention Center, brings together healthcare professionals specializing in infectious diseases, epidemiology and prevention. The EOS team will be available at Booth 333 to discuss infection prevention support through the use of copper-infused Preventive|Biocidals during the conference exhibit hours.

* Testing demonstrates effective antibacterial activity against Staphylococcus aureus (ATCC 6538), Enterobacter aerogenes (ATCC 13048), Methicillin-resistant Staphylococcus aureus (MRSA-ATCC 33592), Escherichia coli 0157:H7 (ATCC 35150), and Pseudomonas aeruginosa (ATCC 15442).

 

 

 



September 25, 2015


Topic Area: Press Release


Recent Posts

On the Lookout: The Software Supply Chain as a Healthcare Cyberattack Vector

Staying watchful of third-party software vendors and their activities is critical for healthcare cybersecurity.


Hackensack Meridian Health & Wellness Center at Clifton Opens

The Clifton center expands health care access in Passaic County by reducing barriers such as travel and wait times.


Suffolk Breaks Ground on Expansion of White Plains Hospital

The 10-story, approximately 500,000-square-foot expansion is slated to open in 2028.


EVS Leadership Culture Critical in Preventing Hospital-Acquired Sepsis

Cleaning is an essential yet complex component for the prevention of HAI-induced sepsis.


Man Dies by Suicide in Emergency Department Waiting Room at Kansas Hospital

No staff or patients were harmed, and the man was alone in the waiting area when he shot himself.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.